GoKawiilNature Index data show China's share of biomedical-engineering papers nearly doubles since 2021
Nature Index figures for 2021-2025 show global biomedical-engineering output growing 70%, faster than the database overall, with the field's share of all tracked papers rising from 2.4% to 2.7%. China's contribution to that output jumped from 28.9% to 50.9%, while the US and Germany held second and third place with roughly steady shares. The analysis also highlights South Korea, Switzerland, Canada and the Netherlands as countries with distinct patterns of specialization, growth or international collaboration in the field.
GoKawiil's interpretation of the reporting above, not reported fact.
The sharp rise in China's share suggests a broader reordering of scientific influence that mirrors trends already seen in other fields tracked by the index, potentially reshaping where future biomedical innovation and talent concentrate. The steadier positions of the US and Germany could indicate that their biomedical-engineering output is growing in line with their overall research base rather than being a strategic priority, while smaller nations' divergent strategies—specialization, collaboration, or private-sector partnership—may offer alternative models for maintaining relevance in a China-dominated landscape.
- Biomedical-engineering papers in the Nature Index grew 70% between 2021 and 2025, outpacing overall database growth.
- China's share of global output in the field rose from 28.9% to 50.9%, while the US and Germany held steady second and third positions.
- South Korea, Switzerland, Canada and the Netherlands show distinct smaller-scale trends in specialization, growth and international collaboration.
Source: nature.com — Yates, 2026-10-14
Published there as: “Nature Index reveals the four countries to watch in biomedical engineering”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.